An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Investigational Treatment Acquiring Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are urged to contact these profiles directly for source information, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Additionally, a flourishing market exists on Telegram, where groups with thousands of participants share comparison images, injection guides and assertions of rapid British shipping. Vendors market the drug there before directing buyers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Worries
Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in users administering products of uncertain source.
Several professionals stated the popularity for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for human use under the British medical regulations.
Several influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still violate pharmaceutical, advertising, and consumer laws, risking fines, legal action or imprisonment.
Platform Reaction and Material Elimination
According to TikTok, the service has removed violative material and prohibited associated hashtags and search suggestions. The organization said it was dedicated to maintaining the platform secure and investing in enhancing compliance measures.
Online Trading Activities
Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, populated with photos of weight loss, positive reviews and step-by-step instructions for preparing or administering at home.
Within minutes of joining one group, a seller posted WhatsApp details, where most purchases occur. The vendor sent an instruction manual and guaranteed delivery within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about weight, health issues or previous experience.
Item Details and Costs
Inside these communities, messages display black plastic parcels with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give conflicting answers varying between a several days to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for Telegram stated it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting materials they can’t verify. Although the science behind retatrutide is sound, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has already encountered patients harmed by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to potentially serious health risks”.
